Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05472012 · ClinicalTrials.gov registry record · NA
Performance of Masimo INVSENSOR00057 in Detecting Atrial Fibrillation (Afib)
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
NCT05472012 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 139 participants.
The verdict
NCT05472012, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
Study Summary
This study is designed to validate the performance of Masimo INVSENSOR00057 in detecting atrial fibrillation. The noninvasive ECG measurements will be compared to results obtained from an FDA-cleared ECG monitor.
Interventions
- DEVICE INVSENSOR00057
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2022-07-25 |
| Est. Completion | 2023-12-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05472012
The ClinicalTrials.gov registry entry for NCT05472012 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00057 is the first listed.
NCT05472012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05472012 about?
NCT05472012 is a clinical study titled "Performance of Masimo INVSENSOR00057 in Detecting Atrial Fibrillation (Afib)". This study is designed to validate the performance of Masimo INVSENSOR00057 in detecting atrial fibrillation. The noninvasive ECG measurements will be compared to results obtained from an FDA-cleared ECG monitor.
What is the current status of trial NCT05472012?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2022-07-25. Estimated completion is 2023-12-16.
What interventions are being tested in trial NCT05472012?
The interventions under investigation include: INVSENSOR00057 (DEVICE).
Who is sponsoring clinical trial NCT05472012?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.